EB 103/1999/REC/1
WORLD HEALTH ORGANIZATION
EXECUTIVE BOARD lOJrd SESSION GENEVA, 25 JANUARY TO 1 FEBRUARY 1999
RESOLUTIONS AND DECISIONS ANNEXES
GENEVA 1999
EB 103/1999/REC/1
WORLD HEALTH ORGANIZATION
EXECUTIVE BOARD 103rd SESSION GENEVA, 25 JANUARY TO 1 FEBRUARY 1999
RESOLUTIONS AND DECISIONS ANNEXES
GENEVA 1999
ABBREVIATIONS Abbreviations used in WHO documentation include the following: ACC ACHR ASEAN CIOMS
- Administrative Committee on Coordination Advisory Committee on Health Research Association of South-East Asian Nations Council for International Organizations of Medical Sciences Economic Commission for Africa Economic Commission for Europe Economic Commission for Latin America and the Caribbean Economic and Social Commission for Asia and the Pacific Economic and Social Commission for Western Asia Food and Agriculture Organization of the United Nations International Atomic Energy Agency International Agency for Research on Cancer International Civil Aviation Organization International Fund for Agricultural Development International Labour Organization (Office) International Maritime Organization International Telecommunication Union
OAU OECD PAHO
- Organization of African Unity - Organisation for Economic Co-operation and Development
- Pan American Health
ECA ECE ECLAC ESCAP
-
ESCWA FAO
-
IAEA IARC ICAO IFAD ILO IMO ITU
-
-
Organization UN AIDS - United Nations Joint Programme on HIV/AIDS UNCTAD- United Nations Conference on Trade and Development UNDCP - United Nations International Drug Control Programme UNDP - United Nations Development Programme UNEP - United Nations Environment Programme UNESCO - United Nations Educational, Scientific and Cultural Organization UNFPA - United Nations Population Fund UNHCR - Office of the United Nations High Commissioner for Refugees UNICEF - United Nations Children's Fund UNIDO - United Nations Industrial Development Organization UNRWA - United Nations Relief and Works Agency for Palestine Refugees in the Near East US AID - United States Agency for International Development WFP - World Food Programme WIPO - World Intellectual Property Organization WMO - World Meteorological Organization World Trade Organization WTO -
The designations employed and the presentation of the material in this volume do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Where the designation "country or area" appears in the headings of tables, it covers countries, territories, cities or areas.
- ii-
PREFACE
The I 03rd session of the Executive Board was held at WHO headquarters, Geneva, from 25 January to 1 February 1999. The proceedings are published in two volumes. The present volume contains the resolutions and decisions, and relevant annexes. The summary records of the Board's discussions, list of participants and officers elected, and details regarding membership of committees and working groups, are published in document EB I 03/1999/REC/2.
- iii -
CONTENTS
Page Preface Agenda....................................................................... List of documents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
1x x1
RESOLUTIONS AND DECISIONS Resolutions EB103.R1 EB103.R2 EB103.R3 EB103.R4 EB103.R5 EB103.R6 EB103.R7 EB103.R8 EB103.R9 EB103.R10 EB103.Rll EB103.R12 EB103.Rl3 EB103.R14 EB103.R15 Revised drug strategy ........................................... . Appointment of the Regional Director for the Americas . . . . . . . . . . . . . . . . . . Appointment of the Regional Director for South-East Asia . . . . . . . . . . . . . . . Appointment of the Regional Director for the Western Pacific . . . . . . . . . . . . . Expression of appreciation to Dr S.T. Han . . . . . . . . . . . . . . . . . . . . . . . . . . . . Budget presentation and process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reimbursement of travel expenses for attendance at regional committees . . . . Establishment of Audit Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ro 11 Back Malaria ......... .................... ............ ..... 4 4 4 5 5 7 8 9 11 12 16 17 18 18
Eradication of poliomyelitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Towards a WHO framework convention on tobacco control . . . . . . . . . . . . . . Status of collection of assessed contributions . . . . . . . . . . . . . . . . . . . . . . . . . . Real Estate Fund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amendments to Financial Regulations and Rules . . . . . . . . . . . . . . . . . . . . . . . Confirmation of amendments to the Staff Rules . . . . . . . . . . . . . . . . . . . . . . . .
- V-
Page
EB103.R16 EB103.R17
Salaries of staff in ungraded posts and of the Director-General WHOIUNICEF/UNFPA Coordinating Committee on Health: Terms of reference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Relations with nongovernmental organizations . . . . . . . . . . . . . . . . . . . . . . . . . Reform ofthe Health Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18
19 20 21
EB103.R18 EB103.R19 Decisions EB103(1)
Representatives of the Executive Board at the Fifty-second World Health Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Review ofnongovernmental organizations in official relations with WHO Provisional agenda for and duration of the Fifty-second World Health Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Date and place ofthe 104th session ofthe Executive Board . . . . . . . . . . . . . . . Revised guidelines for the WHO review of dependence-producing psychoactive substances for international control . . . . . . . . . . . . . . . . . . . . . . . Award ofthe Darling Foundation Prize . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Award ofthe Leon Bernard Foundation Prize . . . . . . . . . . . . . . . . . . . . . . . . . Award ofthe Dr A.T. Shousha Foundation Prize . . . . . . . . . . . . . . . . . . . . . . . Award ofthe Ihsan Dogramaci Family Health Foundation Prize and Fellowship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A ward of the Sasakawa Health Prize . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Award ofthe Francesco Pocchiari Fellowship......... . . . . . . . . . . . . . . . . . Award ofthe United Arab Emirates Health Foundation Prize. . . . . . . . . . . . . . Establishment of the Down Syndrome Research Prize Foundation in the Eastern Mediterranean Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... .
23 23
EB103(2) EB103(3)
24 25
EB103(4) EB103(5)
25 25 26 26
EB103(6) EB103(7) EB103(8) EB103(9)
26 26 26 27
EB103(10) EB103(11) EB103(12) EB103(13)
27
ANNEXES 1. 2. 3. 4. Revised drug strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Real Estate Fund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amendments to Financial Regulations and Rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Confirmation of amendments to the Staff Rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . -vi31 43 46 51
Page
5. 6.
Reform ofthe Health Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nongovernmental organizations maintained in official relations with WHO by virtue of decision EBI03(2)..................................................
56
58
Index to resolutions and decisions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
61
-VII-
AGENDA 1
Item No.
1. 2.
Opening ofthe session and adoption ofthe agenda The Way Ahead for WHO • Director-General Trends and challenges in world health • Presentation by cluster for Evidence and Information for Policy
3.
Technical and health matters • Revised drug strategy • Tobacco Free Initiative • Roll Back Malaria • Poliomyelitis eradication
4. 5.
Role ofthe Executive Board Proposed programme budget for the financial period 2000-2001 Staff development and support • Renewal process • Statement by the representative ofthe WHO staff associations on matters concerning personnel policy and conditions of service • Employment and participation of women in the work of WHO: annual report
6.
7.
Administrative and financial matters • Appointment of the Regional Directors for the Americas, South-East Asia and Western Pacific • Amendments to Articles 2 and 73 of the Constitution
1
As adopted by the Board at its first meeting (25 January 1999).
- ix-
EXECUTIVE BOARD, 103rd SESSION
• Status of collection of assessed contributions including Members in arrears to an extent which would justify invoking Article 7 of the Constitution • Casual income • Real Estate Fund • Amendments to the Financial Regulations and Rules • Report of the International Civil Service Commission • Confirmation of amendments to the Staff Rules • Regulations for Expert Advisory Panels and Committees • WHO/UNICEF/UNFPA Coordinating Committee on Health: terms of reference • Collaboration with nongovernmental organizations: Nongovernmental Organizations • Awards • Provisional agenda for and duration of the Fifty-second World Health Assembly • Date and place of the 104th session of the Executive Board 8. Matters for information • Iodine deficiency • Report on meetings of expert committees and study groups (including report on appointments to expert advisory panels and committees) • United Nations system reform • International Decade ofthe World's Indigenous People • Reports of the Joint Inspection Unit 9. Closure ofthe session report of the Standing Committee on
Supplementary agenda item- Reform ofthe Health Assembly
- X-
LIST OF DOCUMENTS
EB 103/1 Rev.l EB103/2 EB103/3 EB103/4 2 EB103/5 EB103/6 EB103/7 EB103/8 EB103/9 EB103/10 EB103/ll EB103112 EB103/13 EB103/14 EB103/15
Agenda' The way ahead for WHO Trends and challenges in world health Revised drug strategy Tobacco Free Initiative Roll Back Malaria Poliomyelitis eradication Role ofthe Executive Board Renewal process Employment and participation of women in the work of WHO: annual report Appointment of the Regional Director for the Americas Appointment ofthe Regional Director for South-East Asia Appointment of the Regional Director for the Western Pacific Amendment to Article 2 of the Constitution Status of collection of assessed contributions, including Members in arrears to an extent which would justifY invoking Article 7 of the Constitution Casual income Real Estate Fund Amendments to the Financial Regulations and Rules
EB103/16 EBl 03/17 3 EB103/18 4
1 2 3 4
See page ix. See Annex I. See Annex 2. See Annex 3.
-xi-
EXECUTIVE BOARD, 103rd SESSION
EB103/19 EB103/20 1 EB103/21 EB103/22 EB103/23 2
Report of the International Civil Service Commission Confirmation of amendments to the Staff Rules Regulations for expert advisory panels and committees WHO/UNICEFIUNFPA Coordinating Committee on Health: terms of reference Collaboration with nongovernmental organizations: Committee on Nongovernmental Organizations report of the Standing
EB103/24
Revised guidelines for the WHO review of dependence-producing psychoactive substances for international control Provisional agenda for and duration ofthe Fifty-second World Health Assembly Date and place of the 104th session of the Executive Board Iodine deficiency Report on meetings of expert committees and study groups Report on expert advisory panels and committees and their membership United Nations system reform International Decade of the World's Indigenous People Reports of the Joint Inspection Unit Establishment of a regional foundation prize for research in Down syndrome Regular budget allocations to regions, and use of extrabudgetary funds in the regions Amendment to Article 73 of the Constitution Reform ofthe Health Assembly Proposed budget 2000-2001
EB103/25 EB103/26 EB 103/27 EB103/28 EB 103/28 Add.1 EB103/29 EB103/30 EB103/31 EB103/32 EB103/33
EB103/34 EB 103/35 3 PB/2000-2001
Information documents EB 103/INF.DOC./1 Additional budgetary tables
1
See Annex 4. See Annex 6. See Annex 5. -XII-
2 3
LIST OF DOCUMENTS
EB I 03/INF.DOC./2 EB I 03/INF .DOC./3 EB103/INF.DOC./4 and Corr.l EB 103/INF.DOC./5
Statement by the representative of the WHO staff associations Proposed budget 2000-200 I Programme budget 2000-2001
Proposed budget 2000-2001
- xiii -
RESOLUTIONS
EB103.Rl
Revised drug strategy 1
The Executive Board RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Recalling resolutions WHA39.27, WHA41.16, WHA43.20, WHA45.27, WHA47.12, WHA47.13, WHA47.16, WHA47.17, and WHA49.14; Having considered the report of the Director-General on the revised drug strategy;2 Noting the activities of WHO to further the implementation of the revised drug strategy, in particular through support to the development and implementation of national drug policies; the strategy to review and assess the effectiveness of the WHO Ethical Criteria for Medicinal Drug Promotion; the flow of market information; guidelines for drug donations; and model drug information; Recognizing with satisfaction the progress made, and approving WHO's comprehensive response to current and new challenges in the pharmaceutical sector; Commending the strong leadership shown by WHO in promoting the essential drugs concept and national drug policies, which are contributing to the rational use of resources in the pharmaceutical sector and to improved health care; Noting with satisfaction that a number of Member States have adopted guidelines for drug donations that are based on the interagency guidelines issued by WHO, but concerned that inappropriate drug donations, such as donations of expired, mislabelled, inessential products, continue to be common, and further concerned that evaluation of the impact of the guidelines has not yet been completed; Concerned about the situation in which (a) one-third of the world's population has no guaranteed access to essential drugs, and (b) poor quality pharmaceutical raw materials and finished products continue to move in international trade; Noting that there are trade issues which require a public health perspective;
1
See Annex I. Document EBIOI/10, section VII and Corr.l.
2
- I -
2
EXECUTIVE BOARD, 103rd SESSION
Recognizing that the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) provides scope for the protection of public health; Taking note of concerns of many Member States about the impact of relevant international agreements, including trade agreements, on local manufacturing capacity and on access to and prices of pharmaceuticals in developing and least developed countries; Concerned also that drugs continue to be irrationally used by prescribers, dispensers and the general public, and that unethical promotion in developed and developing countries and a lack of access to independent, scientifically validated drug information contribute to such abuse, 1. URGES Member States: (1) to reaffirm their commitment to developing, implementing and monitoring national drug policies and to taking all necessary concrete measures in order to ensure equitable access to essential drugs; (2) to ensure that public health interests are paramount in pharmaceutical and health policies; (3) to explore and review their options under relevant international agreements, including trade agreements, to safeguard access to essential drugs; (4) to establish and enforce regulations that ensure good uniform standards of quality assurance for all pharmaceutical materials and products manufactured in, imported to, exported from, or in transit through their countries; (5) to enact and enforce legislation or regulations in accordance with the principles of the WHO Ethical Criteria for Medicinal Drug Promotion, to encourage the pharmaceutical industry and the health community to establish an ethical code, and to monitor drug promotion in collaboration with interested parties; (6) to develop or maintain national guidelines governing drug donations that are compatible with the interagency guidelines issued by WHO and to work with all interested parties to promote adherence to such guidelines; (7) to promote the rational use of drugs through the provision of independent, up-to-date and comparative drug information, and to integrate the rational use of drugs and information about commercial marketing strategies into training for health practitioners at all levels; (8) to promote and support education of consumers in the rational use of drugs and its inclusion into school curricula; (9) to evaluate progress regularly, making use of indicators developed by WHO or of other suitable mechanisms; (1 0) to continue their funding and material support for the revised drug strategy, especially through the provision of extrabudgetary resources to WHO;
RESOLUTIONS AND DECISIONS
3
2.
REQUESTS the Director-General: (1) to support Member States in their efforts to develop and implement policies and programmes that achieve the objectives of the revised drug strategy, including the development of tools, guidelines and methodology for evaluation and monitoring;
(2) to adopt a comprehensive strategy to implement the WHO Ethical Criteria for Medicinal Drug Promotion and to continue to review its effectiveness with all interested parties; (3) to extend the guidelines incorporated in the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce to cover pharmaceutical starting materials; to develop and disseminate uniform guidelines on the regulatory control, export, import and transit conditions of pharmaceutical products; and to develop standards of practice for entities involved in international trade in pharmaceuticals and pharmaceutical starting materials; (4) to establish and develop a model inspection certificate for the national inspection of pharmaceutical manufacturing sites of starting materials and finished pharmaceutical products in order to ensure compliance with WHO Good Manufacturing Practices, and to collaborate with Member States, at their request, in implementation; (5) to strengthen and expand the provision of independent information on market prices of starting materials of assured quality for production of essential drugs; (6) to continue the development and dissemination, also using electronic media such as the Internet, of independent information on safety of pharmaceutical products and instances of counterfeit drugs or medicines, on drug selection and on rational prescribing; (7) to cooperate with Member States, at their request, and with international organizations in monitoring and analysing the pharmaceutical and public health implications of relevant international agreements, including trade agreements, so that Member States can effectively assess and subsequently develop pharmaceutical and health policies and regulatory measures that address their concerns and priorities, and are able to maximize the positive and mitigate the negative impact of those agreements; (8) to review and update the revised drug strategy to reflect current and continued challenges in the pharmaceutical sector and the principles articulated in the renewed healthfor-all policy; (9) to report to the Fifty-third World Health Assembly on progress achieved and problems encountered in the implementation and renewal of WHO's revised drug strategy, with recommendations for action. (Third meeting, 26 January 1999)
4
EXECUTIVE BOARD, 103rd SESSION
EB103.R2
Appointment of the Regional Director for the Americas
The Executive Board, Considering the provisions of Article 52 of the Constitution and StaffRegu1ation 4.5; Considering the nomination and recommendation made by the Regional Committee for the Americas at its fiftieth session, 1. REAPPOINTS Sir George Alleyne as Regional Director for the Americas, as from 1 February 1999;
2. AUTHORIZES the Director-General to issue a contract to Sir George Alleyne for a period of four years from 1 February 1999, subject to the provisions of the Staff Regulations and Staff Rules. (Fourth meeting, 26 January 1999)
EB103.R3
Appointment of the Regional Director for South-East Asia
The Executive Board, Considering the provisions of Article 52 of the Constitution and Staff Regulation 4.5; Considering the nomination and recommendation made by the Regional Committee for South-East Asia at its fifty-first session, I. REAPPOINTS Dr Uton Muchtar Rafei as Regional Director for South-East Asia as from 1 March I999; 2. AUTHORIZES the Director-General to issue to Dr Uton Muchtar Rafei a contract for a period of five years from 1 March I999, subject to the provisions of the Staff Regulations and Staff Rules. (Fourth meeting, 26 January 1999)
EB103.R4
Appointment of the Regional Director for the Western Pacific
The Executive Board, Considering the provisions of Article 52 of the Constitution and Staff Regulation 4.5; Considering the nomination and recommendation made by the Regional Committee for the Western Pacific at its forty-ninth session, 1. APPOINTS Dr Shigeru Omi as Regional Director for the Western Pacific as from 1 February 1999;
2. AUTHORIZES the Director-General to issue to Dr Shigeru Omi a contract for a period of five years from I February I999, subject to the provisions of the Staff Regulations and Staff Rules. (Fourth meeting, 26 January I999)
RESOLUTIONS AND DECISIONS
5
EB103.R5
Expression of appreciation to Dr S. T. Han
The Executive Board, Desiring, on the occasion ofthe retirement ofDr S.T. Han as Regional Director for the Western Pacific, to express its appreciation of his services to the World Health Organization; Mindful of his lifelong devotion to the cause of international health, and recalling especially his 10 years of service as Regional Director for the Western Pacific, 1. EXPRESSES its profound gratitude and appreciation to Dr S.T. Han for his invaluable contribution to the work of WHO; 2. ADDRESSES to him on this occasion its sincere good wishes for many further years of service to humanity. (Fourth meeting, 26 January 1999)
EB103.R6
Budget presentation and process
The Executive Board, Recalling resolutions WHA46.35, WHA48.25, EB99.Rl3 and EBIOI.Rl on continued development of a strategic approach to budget development, presentation and evaluation; Endorsing the joint report of the Administration, Budget and Finance Committee and the Programme Development Committee on their discussion of the Proposed budget 2000-2001; Welcoming the efforts of the Director-General to revitalize WHO through a process of restructuring and streamlining; Commending the Director-General on the substantive progress made in the presentation of the Proposed budget 2000-2001 in the very short time available since taking office; Welcoming the clarity of the programme descriptions for clusters, outlining issues, objectives and expected results; Welcoming the integrated presentation of regular and extrabudgetary funds indicating total resources associated with cluster programmes, but registering concern over the basing of programme achievements on the full realization of the ambitious 19% targeted increase in extrabudgetary resources; Welcoming the correspondence between the budget and the management structures, and expecting a uniform presentation by cluster of headquarters and regional programmes; Reiterating that a strategic approach to results-based budgeting is founded on a clear statement of cluster and departmental objectives in terms of measurable results for a specific period, and on a process for continuous monitoring of progress and reporting of results to governing bodies; Noting the need to deliver programme objectives and results in the most efficient manner;
6
EXECUTIVE BOARD, I 03rd SESSION
Encouraging greater transparency in identifying actual p~ogramme allocations and expenditures, including the basis on which cost increases are calculated, from all external and internal sources; Noting the need of governing bodies to have timely reports to enable them to provide judgements on progress, adjustments required on programme activities, value for money, and achievement of results, as requested in resolution EB I 0 l.R I; Acknowledging the increased emphasis now being given within WHO to evaluation plans and methodologies, including targets for expected results, cluster by cluster; Recognizing the complexities of the transition now under way in WHO, I. COMMENDS the Director-General on progress made in advancing the concept of a strategic approach to programme preparation and presentation; 2. REQUESTS the Director-General to consider:
A.
prior to the Fifty-second World Health Assembly: (1) providing information on the administrative costs of each cluster;
(2) further defining in measurable terms the specific targets and results for the Proposed budget 2000-200 I; (3) presenting a preliminary outline ofkey indicators for measuring achievements of results against the stated cluster and departmental programmes; (4) clarifying, to the extent possible, expected sources of extrabudgetary resources and actions planned to raise such resources, and the impact on programme activities if targets are not reached, by prioritizing statements of results; (5) providing an overview of two or three key evaluation findings and lessons learned for each cluster during the current biennium, indicating any consequent adjustments made to programme activities or delivery strategies; ( 6) presenting the budget in a format that includes regional programme activities in the cluster structure in order to permit judgements on relative priorities across the entirety of WHO's regular budget; (7) providing a budget table tracking programme allocations from the I998-1999 biennium into the cluster structure for the 2000-200I biennium; presenting an interim report on actual expenditures for the 1998-I999 programme (8) budget, with indications of any further reallocations to priority programmes; (9) providing indicative resource allocations within the related cluster for Cabinet, and any other major, projects based on intercluster cooperation; (1 0) presenting actual staffing tables (as opposed to posts), with budget and actual expenditures, showing trend lines for the past decade on numbers, grades and costs of senior salaried personnel (P.6 and above), and contracted personnel at all grades, including the specific number on Il-month contracts;
RESOLUTIONS AND DECISIONS
7
(11) providing budgetary and actual expenditures for the last decade (1988 to 1998), including transfers to the regular budget from internal sources; B. for future programme budgets: (1) developing, for consideration by the Executive Board at its 105th session in January 2000, an integrated plan for monitoring, evaluating and reporting results to the governing bodies, including any programme adjustments derived from evaluation results and lessons learned, and any programme reorientation requiring Executive Board guidance; (2) drawing up a plan for efficiency savings in nonprogramme costs in order to ensure that maximum resources are made available for programme activities; (3) defining more precisely WHO's role in- working with specific partners to mobilize global support for WHO's health agenda, with indicators of success; (4) providing an evaluation of the new management support units, comparing their performance with that of the previous system. (Seventh meeting, 28 January 1999)
EB103.R7
Reimbursement of travel expenses for attendance at regional committees
The Executive Board RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Recalling resolution WHASO.l on reimbursement of travel expenses for attendance at the Health Assembly and resolution WHA34.4 on reimbursement oftravel costs of representatives to regional committees; Noting the inconsistency in the criteria for reimbursement of travel expenses contained in these two resolutions and desiring to harmonize policies on reimbursement, DECIDES that the actual travel expenses of one representative to sessions of regional committees may be financed by the Organization upon the request of those Members and Associate Members that are classified as least developed countries, the maximum reimbursement being restricted to the equivalent of one economy or tourist return air ticket from the capital city of the Member to the place of the session. (Seventh meeting, 28 January 1999)
8
EXECUTIVE BOARD; 103rd SESSION
EB103.R8
Establishment of an Audit Committee
The Executive Board, Recalling earlier discussions on the subject of establishing an audit committee for the purpose of strengthening the Board's oversight role in financial matters; Noting the report by the Secretariat on the matter, 1 DECIDES to establish an audit committee, as a separate committee set up by the Executive Board, composed of six members, one from each ofthe WHO regions, with the terms of reference set out below: (1)
Objectives The objectives of the Audit Committee, in matters relating to external and internal audit, are: • to assist the Board in providing oversight of the Organization's financial and managerial operations; • to promote accountability and transparency in financial transactions; • to facilitate timely communication and corrective action.
(2)
Scope and functions
The Audit Committee shall devote its attention to both external and internal audit plans and activities, the review of internal controls, and the monitoring of corrective action. Within this framework, the functions ofthe Committee shall be: • to assist the Board, and through it the Health Assembly, to make informed decisions with regard to the financial and managerial policies and practices of the Organization; • to assess the extent of the maintenance of effective financial controls; • to assess the effectiveness of both external and internal annual audit coverage, ensuring that emphasis is laid on areas where the Committee believes special attention is necessary; • to review the scope and outcome of such audits as it deems appropriate, and their follow-up by the Secretariat; • to report to the Board on any matters arising from the above functions, and to submit such conclusions and recommendations thereon as the Committee deems appropriate. (3) Membership, selection and terms of office
Membership ofthe Audit Committee shall be open both to full members of the Board and to their alternates. In order to ensure the best quality of its members, candidatures for the Audit Committee shall be backed up by standard curricula vitae, highlighting the candidates' background in financial, audit and managerial matters. The External Auditor shall participate in the meetings as an observer.
1
Document EBABFCI0/3.
RESOLUTIONS AND DECISIONS
9
Selection of members ofthe Audit Committee shall be undertaken during the short session ofthe Executive Board, immediately after the annual Health Assembly. A first meeting to constitute the Committee and select a Chairman should also be held at that time. Two other meetings of the Audit Committee shall be held annually, one immediately before the opening of the Health Assembly and one before the January session of the Board. The tem1 of office of members of the Audit Committee shall be as detennined by the Board in each instance but, in order to ensure continuity, it would preferably be for at least two years. (Ninth meeting, 29 January 1999)
EB103.R9
Roll Back Malaria
The Executive Board, Reaffirming the impact of malaria in constraining human development, and appreciating the innovative concepts and operational mechanisms in the Director-General's report on Roll Back Malaria,' RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Having considered the report of the Director-General on Roll Back Malaria; Concerned that the global burden of malaria is a challenge to human development and a significant cause of poverty and human suffering, particularly in the poorest nations of the world; Mindful of the efficacious tools currently available to reduce this burden, and the potential for their more effective use within malaria-affected communities; Welcoming the decision by the Director-General to establish a Cabinet project to support rolling back malaria which works across the Organization; Noting that Roll Back Malaria represents a new approach promoted by WHO, in which all concerned parties are encouraged to work in a coordinated partnership, united by common goals, consistent strategies and agreed methods of working, and that Roll Back Malaria is serving as a pathfinder in bringing these concepts into operation in relation to other international health issues; Commending the key features of the new approach, namely, increased focus on the needs of people at risk, better response to those needs with evidence-based. action, greater use of existing tools, their full integration into the health sector as a horizontal programme, and innovative publicprivate partnerships to develop cost-effective products and tools in view of the emergence of drug and insecticide resistance; Appreciating the strong commitment to Roll Back Malaria from several heads of State, the Administrator ofUNDP, the President of the World Bank, the Executive Director of UNICEF, and
1
Document EB 103/6.
10
EXECUTIVE BOARD, 103rd SESSION
directors of other development banks, foundations and bilateral assistance agencies, expressed when the global partnership was established in December 1998, 1. ENCOURAGES Member States to reduce malaria-related suffering and promote national development in a sustained way by rolling back malaria and preventing its resurgence or reintroduction, by: (1) engaging a wide range of personnel and institutions involved in health systems, disease control, and research, with representatives of civil society, the private sector, development agencies and other sectors; and, where relevant, by: (2) ensuring that sufficient resources are available to meet the challenge of rolling back malaria; (3) establishing and sustaining country-level partnerships to roll back malaria within the context of health sector and human development; (4) utilizing relevant technical expertise that exists within countries and regions in an effective manner; 2. REQUESTS the Director-General to draw on the whole Organization in supporting Member States by: (1) promoting harmonized strategies and encouraging consistent technical guidance for efforts to roll back malaria; (2) working with them as they establish criteria for success in rolling back malaria, and monitoring progress of country and global efforts within the context of health sector and human development; (3) promoting international investment in cost-effective new approaches and products through focused support for research and for strategic public and private initiatives; (4) 3. brokering the technical and financial support that is required for success;
REQUESTS the Director-General: (1) to report regularly on progress of the global Roll Back Malaria partnership to the Executive Board and the Health Assembly, stressing the contribution that Roll Back Malaria makes to the reduction of poverty, and reviewing the extent to which the partnership serves as a pathfinder for effective joint action on other international health issues; (2) to promote the aims and outcomes of the Roll Back Malaria partnership in relevant intergovernmental bodies, organizations of the United Nations system, and - when appropriate- other bodies committed to equitable human development. (Ninth meeting, 29 January 1999)
RESOLUTIONS AND DECISIONS
11
EB103.R10
Eradication of poliomyelitis
The Executive Board, Noting the report of the Director-General on the global eradication of poliomyelitis, 1 RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Reaffirming WHO's commitment to the global eradication of poliomyelitis by the end of the year 2000; Recognizing that substantial progress has been made towards eradication of poliomyelitis, with large geographic areas of the world now free of the disease, and a fall of 85% in annually reported cases since global eradication began in 1988; Noting that, as of May 1999, poliomyelitis remains endemic in a number of countries of southern and western Asia and the African continent, some of which are either affected by conflict or constitute densely populated wild poliovirus "reservoirs"; Realizing that civil strife and funding shortfalls represent the two major obstacles to achieving poliomyelitis eradication; Affirming that poliomyelitis eradication will have humanitarian and economic benefits for all countries, I. URGES poliomyelitis-endemic Member States to accelerate eradication activities by conducting additional immunization rounds each year, on either a national or subnational basis; to improve the quality of national immunization days by ensuring that every child is reached; to implement house-to-house "mopping-up" campaigns; and to enhance surveillance by ensuring that all cases of acute flaccid paralysis are detected and promptly investigated; 2. URGES poliomyelitis-free Member States: (1) to sustain high levels of immunization coverage until eradication is certified globally;
(2) to maintain high quality surveillance for importation of wild poliovirus and establish action plans for rapidly responding to such events; 3. URGES all Member States: (1) to mobilize the human and financial resources necessary to accelerate eradication in poliomyelitis-endemic countries;
(2) to support the peace-building process by facilitating ceasefires for national immunization days in countries affected by conflict;
1
Document EB I 03/7.
12
EXECUTIVE BOARD, 103rd SESSION
(3) to support the work of the poliomyelitis eradication initiative in strengthening health systems and services; (4) to begin, in collaboration with WHO, the process leading to the laboratory containment of wild poliovirus; 4. REQUESTS the Director-General: (1) to urge all partners to facilitate acceleration of the initiative to eradicate poliomyelitis during the critical period 1999 to 2001;
(2) to facilitate, when necessary, coordinated mass immunization activities in bordering areas of Member States and WHO regions; (3) to collaborate with other organizations of the United Nations system and other international bodies in arranging ceasefires for poliomyelitis eradication and facilitating eradication activities in countries affected by conflict; (4) to help mobilize the necessary financing to implement eradication activities, including establishment of an emergency fund to meet the needs of countries affected by conflict, countries classified as major wild poliovirus reservoirs, and other countries in particularly difficult circumstances, and to draw upon the strengths of the regional offices in the use of these resources; (5) to collaborate with Member States in the establishment of a mechanism for overseeing the process of laboratory containment ofwild poliovirus; (6) to facilitate ongoing research to define the optimum strategy for eventually stopping immunization against poliomyelitis. (Ninth meeting, 29 January 1999)
EB103.Rll
Towards a WHO framework convention on tobacco control
The Executive Board, Recognizing the leadership of WHO in the field of tobacco control, and having considered the report of the Director-General on the Tobacco Free Initiative 1 and the outline of expected activities annexed to this resolution, RECOMMENDS to the Fifty-second World Health Assembly, the adoption of the following resolution: The Fifty-second World Health Assembly, Being deeply concerned by the escalation of smoking and other forms of tobacco use worldwide, which resulted in the loss of at least 3.5 million human lives in 1998 and is expected to
1
Document EB103/5.
RESOLUTIONS AND DECISIONS
13
cause at least 10 million deaths ayearby2030 ifthe pandemic is not controlled, with 70% ofthese deaths occurring in developing countries; Having considered the report of the Director-General to the Health Assembly on the Tobacco Free Initiative, and the outline of expected activities; Recognizing the leadership of the Director-General and WHO in the field of tobacco control; Recalling and reaffirming resolution WHA49.17 requesting the Director-General to initiate development of a WHO framework convention on tobacco control in accordance with Article 19 of the WHO Constitution; Recognizing the need for multisectoral strategies, including the involvement of other multilateral organizations and nongovernmental organizations, to foster international consensus and action on development of the WHO framework convention on tobacco control and possible related protocols; Being mindful of the many constraints, including resource constraints, faced by a number of countries in the development and implementation of the WHO framework convention on tobacco control and possible related protocols; Being also mindful of the fact that tobacco production is a significant source of earnings in many developing countries; Being aware of the urgent need to speed up work on the proposed WHO framework convention on tobacco control and possible related protocols so that they may serve as a basis for multilateral cooperation and collective action on tobacco control; Desiring to complete preparation of the draft text of the framework convention for consideration by the Fifty-sixth World Health Assembly, 1. DECIDES: ( 1) in accordance with Rule 42 of its Rules of Procedure, to establish an intergovernmental negotiating body open to all Member States to draft and negotiate the proposed WHO framework convention on tobacco control and possible related protocols; (2) to establish a working group on the WHO framework convention on tobacco control open to all Member States in order to prepare the work of the body referred to above. This group will prepare proposed draft elements of the WHO framework convention on tobacco control. The working group will report on progress to the Executive Board at its 105th session. It will complete its work and submit a report to the Fifty-third World Health Assembly; 2. URGES Member States: (1) to give high priority to accelerating work on development of the WHO framework convention on tobacco control and possible related protocols;
(2)
to provide resources and cooperation necessary to accelerate the work;
14
EXECUTIVE BOARD, 103rd SESSION
(3) to promote intergovernmental consultations ~o address specific issues, for example, public health matters and other technical matters relating to negotiation of the proposed WHO framework convention on tobacco control and possible related protocols; (4) to establish national commissions for the WHO framework convention on tobacco control where appropriate; (5) to facilitate and support the participation of nongovernmental organizations, recognizing the need for multisectoral representation; (6) to consider further development and strengthening of national and regional tobacco policies, including the appropriate application of regulatory programmes to reduce tobacco use, as contributions to development of the framework convention and possible related protocols; 3. REQUESTS the Director-General: (1) to promote support for development of the WHO framework convention on tobacco control and possible related protocols among Member States, organizations of the United Nations system, other intergovernmental, nongovernmental and voluntary organizations, and the media;
(2) to complete the technical work required to facilitate negotiations on the WHO framework convention on tobacco control and possible related protocols; (3) to convene the working group on the WHO framework convention on tobacco control, and the first meeting of the intergovernmental negotiating body on the basis of progress achieved by the working group; (4) to provide the working group on the WHO framework convention on tobacco control and the intergovernmental negotiating body with the necessary services and facilities for the performance of their work; (5) to facilitate the participation of the least developed countries in the work of the working group on the WHO framework convention on tobacco control, in intergovernmental technical consultations, and in the intergovernmental negotiating body; (6) to invite, as observers at the sessions of the working group on the WHO framework convention on tobacco control and the intergovernmental negotiating body, representatives of non-Member States, of liberation movements referred to in resolution WHA27.37, of organizations of the United Nations system, of intergovernmental organizations with which WHO has established effective relations, and of non governmental organizations in official relations with WHO, who will attend the sessions of those bodies in accordance with the relevant Rules of Procedure and resolutions of the Health Assembly.
RESOLUTIONS AND DECISIONS
15
Annex
OUTLINE OF EXPECTED ACTIVITIES January 1999 to May 2000 (completion of pre-negotiation phase), and targets for negotiation and adoption of the WHO framework convention on tobacco control and possible related protocols (May 2000 to May 2003) Milestones January 1999 Governing and subsidiary bodies Executive Board Decision and actions by governing and subsidiary bodies • Recommend for adoption by the Fifty-second World Health Assembly the resolution "Towards a WHO framework convention on tobacco control" Action by the Secretariat After the 103rd session ofthe Executive Board • Disseminate information on the process for developing the framework convention • For the Fifty-second World Health Assembly, prepare briefing document(s) on the wocess • old consultations with Member States • Hold briefing sessions on the framework convention during the Fifty-second World Health After the ifty-second World Health Assembly • Support intergovernmental technical consultations on the framework convention • Facilitate participation of least developed countries in the process for developing the framework convention • Provide technical support • Convene the working group on the WHO framework convention on tobacco control • Provide technical support • Provide technical support Assembl~
May 1999
Fifty-second World Health Assembly
• Consider the draft resolution "Towards a WHO framework convention on tobacco control" • Establish the intergovernmental negotiating body and the working group on the framework convention on tobacco control
May 1999 to January 2000
Working group on the framework convention
• Initiate preparation of proposed draft elements of the WHO framework convention on tobacco control • Submit progress report of the working group on the framework convention to the Executive Board at its 105th session • Consider the progress of the working group • Continue work based on direction from the Executive Board • Submit report of the working group on the framework convention to the Fifty-third World Health Assembly • Hold the first organizational session
January 2000
Working group on the framework convention Executive Board
January 2000 to May 2000 May 2000
Working group on the framework convention Fifty-third World Health Assembly
• Provide technical support
• Hold technical briefing during the Health Assembly on alternative negotiation processes • Convene the first meeting of the intergovernmental negotiating body based on progress achieved by the working group
May 2000 (target date)
Intergovernmental negotiating body
• Provide technical support Intergovernmental • Negotiate the draft framework May 2000 to May 2003 negotiating body convention and possible related (Target date protocols for adoption) Note: Process and content will be dnven pnmanly by Member States, but will also mclude mput from bodies of the United Nations system, other international, regional, or intergovernmental organizations, and nongovernmental organizations. (Tenth meeting, 29 January 1999)
16
EXECUTIVE BOARD, 103rd SESSION
EB103.R12
Status of collection of assessed contributions
The Executive Board, Having considered the report of the Director-General on the status of collection of assessed contributions; 1 Taking into account the genuine difficulties faced by some developing countries arising out of adverse international economic factors beyond their control, and also realizing that these conditions may continue for longer than expected, 1. EXPRESSES its deep concern at: ( 1) (2) the continuing high level of outstanding contributions by Member States; the effect of such delays on the programme of work approved by the Health Assembly;
2. URGES Members that are in arrears to pay their outstanding contributions before the Fifty-second World Health Assembly; 3. RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Noting with concern that, as at 31 December 1998:
(1) the rate of collection in 1998 of contributions to the effective working budget for that year amounted to 77.94%, leaving US$ 92 373 784 unpaid; (2) only 105 Members had paid their contributions to the effective working budget for that year in full, and 63 Members had made no payment; (3) total unpaid contributions in respect of 1998 and prior years exceeded US$ 180 million,
1. EXPRESSES deep concern at the continuing high level of outstanding contributions, which has had a deleterious effect on programmes and on the financial situation of the Organization; 2. CALLS THE ATTENTION of all Members to Financial Regulation 5.6, which provides that instalments of contributions shall be considered as due and payable in full by the first day of the year to which they relate, and to the importance of paying contributions as early as possible to enable the Director-General to implement the budget in an orderly manner; 3. REMINDS Members that, as a result of the adoption, by resolution WHA41.12, of an incentive scheme to promote the timely payment of assessed contributions, those that pay their assessed contributions early in the year in which they are due will have their contributions payable for a subsequent budget reduced appreciably, whereas Members paying later will see their contributions payable for that subsequent budget reduced only marginally or not at all;
1
Document EB I 03/15.
RESOLUTIONS AND DECISIONS
17
4. URGES Members that are systematically late in the payment of their contributions to take immediate steps to ensure prompt and regular payment; 5. REQUESTS the Director-General and the Regional Directors to intensifY contacts with Member States to pay their outstanding contributions; 6. REQUESTS the Director-General to review, taking into account developments in other organizations in the United Nations system, current financial arrangements and to propose other possibilities to promote early payments with a view to ensuring a sound financial basis for programmes, and to report on this matter to the Executive Board at its 105th session and to the Fifty-third World Health Assembly; 7. FURTHER REQUESTS the Director-General to draw this resolution to the attention of all Members. (Tenth meeting, 29 January 1999)
EB103.R13
Real Estate Fund
The Executive Board, Noting the report of the Director-General on the status of projects being financed from the Real Estate Fund and the estimated requirements of the Fund for the period 1 June 1999 to 31 May 2000; 1 Noting further that funds from previously approved projects for the Regional Office for Africa, the Regional Office for the Americas and the Regional Office for South-East Asia, totalling US$ 2 049 000, are unlikely to be used in the current biennium, RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Having considered the report of the Director-General on the status of projects financed from the Real Estate Fund and the estimated requirements of the Fund for the period 1 June 1999 to 31 May 2000; Recognizing that certain estimates must necessarily remain provisional, 1. AUTHORIZES the financing from the Real Estate Fund of the expenditures indicated under Section Ill of the Director-General's report, at an estimated cost of US$ 50 000; 2. AUTHORIZES the transfer from the Real Estate Fund to Casual Income of the amount of US$ 2 049 000. (Tenth meeting, 29 January 1999)
1
See Annex 2.
18
EXECUTIVE BOARD, I 03rd SESSION
EB103.R14
Amendments to Financial Regulations and Rules
The Executive Board, Having considered the report of the Director-General on the proposed amendments to the Financial Regulations and Rules, 1 RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution: The Fifty-second World Health Assembly, Having considered the amendments to the Financial Regulations proposed by the DirectorGeneral and endorsed by the Executive Board at its I 03rd session, I. ADOPTS the proposed amendments to the Financial Regulations;
2. CONFIRMS the amendments to the Financial Rules as annexed to the Director-General's report. (Tenth meeting, 29 January 1999)
EB103.R15
Confirmation of amendments to the Staff Rules 2
The Executive Board CONFIRMS in accordance with StaffRegulation 12.2 the amendments to the Staff Rules that have been made by the Director-General with effect from I January 1999 concerning dependency allowances for the professional and higher graded categories; with effect from the school year in force on I January 1999 concerning the education grant; and with effect from I March 1999 concerning the salary scale and staff assessment rates for use in conjunction with gross base salaries applicable to staff in the professional category and directors' posts. (Tenth meeting, 29 January 1999)
EB103.R16
Salaries of staff in ungraded posts and of the Director-General2
The Executive Board RECOMMENDS to the Fifty-second World Health Assembly the adoption of the following resolution regarding salaries of staff in ungraded posts and of the Director-General: The Fifty-second World Health Assembly, Noting the recommendation of the Executive Board with regard to remuneration of staff in ungraded posts and ofthe Director-General,
1
See Annex 3. See Annex 4.
2
RESOLUTIONS AND DECISIONS
19
1. ESTABLISHES the salary for ungraded posts at US$ 13 7 683 per annum before staff assessment, resulting in a modified net salary of US$ 95 995 (dependency rate) or US$ 86 926 (single rate); 2. ESTABLISHES the salary for the Director-General at US$ 186 094 per annum before staff assessment, resulting in a modified net salary of US$ 126 494 (dependency rate) or US$ 112 488 (single rate); 3. DECIDES that those adjustments in remuneration shall take effect on 1 March 1999. (Tenth meeting, 29 January 1999)
EB103.R17
WHOIUNICEF/UNFPA Coordinating Committee on Health: Terms of reference
The Executive Board, Noting the report on the terms of reference ofthe WHOIUNICEF/UNFPA Coordinating Committee on Health, 1 1. APPROVES the terms of reference for the Coordinating Committee on Health as proposed by the Director-General in consultation with the Executive Director of UNICEF, the Executive Director of UNFPA and as recommended by the Committee at its first meeting (WHO, Geneva, 3 and 4 July 1998), and annexed to this resolution; 2. REQUESTS the Director-General to transmit this resolution to the Executive Boards of UNICEF and UNFPA.
Annex WHOIUNICEFIUNFPA COORDINATING COMMITTEE ON HEALTH TERMS OF REFERENCE
1. The WHO/UNICEF/UNFPA Coordinating Committee on Health shall meet biennially, or in special session if required, normally in Geneva. The Committee shall be chaired in rotation by a member of the Executive Board of each organization; WHO, as the lead agency in international health, will chair the first session. 2. The role of the Committee will be: - to facilitate the coordination of health policies and programmes ofthe three organizations; - to review the overall needs for strategic, operational and technical coordination in the fields of maternal, child, adolescent and women's health, with a prioritized focus on disease and health
1
Document EB I 03/22.
20
EXECUTIVE BOARD, 103rd SESSION
ramifications based on WHO mortality and morbidity statistics, and reproductive health, including family planning and sexual health, to ensure regular exchange of information in these areas and to make recommendations to the respective Executive Boards for follow-up action by the secretariats, as appropriate, with due regard for the respective mandates of the organizations involved; - to promote consistency in implementation strategies and activities among the three organizations and with other partners, for the maximum benefit of Member States, especially at the country level within the context of the Resident Coordinator system and, in this context, to ensure that these are guided by the overall policy framework for health development as defined by the World Health Assembly; - to receive and review progress and assessment reports presented by the Director-General of WHO, the Executive Director of UNICEF or the Executive Director ofUNFPA, on activities pertaining to the health of children, young people and women, with a prioritized focus on disease and health ramifications based on WHO mortality and morbidity statistics, including reproductive health, and to review any orientation of strategy that may be necessary to meet agreed objectives, with due regard for the respective mandates of the agencies involved; - to consider matters of common concern to WHO, UNICEF and UNFPA which the Executive Boards or the secretariats of the respective organizations may refer to this Committee; - to report to the WHO, UNICEF and UNFPA Executive Boards on the foregoing matters. 3. The WHO/UNICEFIUNFPA Coordinating Committee on Health shall be composed of 16 members of the Executive Boards of the three organizations, such members being selected by their respective Boards on the basis of one from each region of the organization concerned. 4. WHO shall provide the Secretariat for the Committee and, in consultation with UNICEF and UNFPA, jointly convene intersecretariat meetings to prepare the agenda and supporting documentation for the sessions ofthe Committee. 5. Further intersecretariat meetings may be convened in alternate years, where appropriate with other organizations active in health, to ensure a coordinated approach at country level. (Tenth meeting, 29 January 1999)
EB103.R18
Relations with nongovernmental organizations
The Executive Board, Having examined the report of its Standing Committee on Non governmental Organizations, 1 I. DECIDES to establish official relations with the following nongovernmental organizations: German Pharma Health Fund e. V. International Federation of Anti-Leprosy Associations International Society of Andrology;
1
Document EBI03/23.
RESOLUTIONS AND DECISIONS
21
2. DECIDES to defer for two years consideration of an application from the World Federation of Building Service Contractors and, in the meantime, to strengthen joint activities; 3. RECORDS that the International Federation of Red Cross and Red Crescent Societies, which, at its request, is invited to attend the Health Assembly as an observer, is no longer in official relations with WHO as a nongovernmental organization; 4. DECIDES to discontinue official relations as a nongovernmental organization with the International Federation for Family Life Promotion, the International Union of Family Organisations, and the International Academy of Legal Medicine. (Eleventh meeting, 1 February 1999)
EB103.R19
Reform of the Health Assembly
The Executive Board, Having considered the report by the Secretariat on reform of the Health Assembly, concerning participation of high-level policy-makers in its work;' Recalling resolution WHA50.18 concerning arrangements for the conduct of the discussion in plenary meetings on the annual report of the Director-General; Noting that the current arrangements do not serve fully to engage high-level policy-makers in the work ofthe Health Assembly; Noting further that some organizations in the United Nations system have established mechanisms to facilitate the interaction of high-level policy-makers at their governing bodies, 1. ENDORSES, as an interim arrangement, the proposal of the Director-General to incorporate in the provisional agenda and the preliminary daily timetable for the Fifty-second World Health Assembly ministerial round tables on lessons learned in world health in order to enhance the involvement of ministers of health in policy discussions; 2. RECOMMENDS that the Health Assembly should evaluate the interim arrangement with a view to revising the arrangements for the conduct of its proceedings at subsequent Assemblies, including measures to promote the interaction and participation of ministers; 3. REQUESTS the Director-General to report to the Executive Board at its 105th session on experience gained. (Eleventh meeting, 1 February 1999)
1
See Annex 5.
DECISIONS
EB103(1)
Appointment of representatives of the Executive Board at the Fifty-second World Health Assembly
The Executive Board appointed Mr Liu Peilong (China) as a representative of the Board at the Fiftysecond World Health Assembly in addition to its Chairman, Dr K. Calman (United Kingdom of Great Britain and Northern Ireland), ex officio, Dr A. Sanou Ira (Burkina Faso) and Dr K.A. Al-Jaber (Qatar), already appointed at its 102nd session. (First meeting, 25 January 1999)
EB103(2)
Review ofnongovernmental organizations in official relations with WH0 1
The Executive Board, having considered the report of its Standing Committee on Nongovernmental Organizations on the review of one-third of the nongovernmental organizations in official relations with WHO/ and following up decision EB 101 (15), reached the decisions set out below. Noting the determination of 46 of the nongovernmental organizations to maintain collaboration with WHO during the period under review, which had resulted in activities serving to further WHO's work in the following areas: improving the lives of people and their families coping with the adversities of mental and neurological disorders and physical disabilities; exploring such issues as female genital mutilation and research on contraceptive methods relating to reproductive health, including safe motherhood; collaborating with youth organizations in order to learn the elements of a safe and supporting environment for the optimum development of young people; coordinating efforts to achieve the goal of eliminating iodine deficiency; providing support for training in breastfeeding, preparation of educational materials, and creation of training opportunities for scientists and nutrition workers in developing countries so as to improve food safety; and drawing up international guidelines on good practices in health and environment management in industry and other workplaces, the Board decided to maintain official relations with those organizations. Concerning the International Society for the Study of Behavioural Development, the Board noted with regret that collaboration had ceased, although a mutual interest in cooperation had resulted in the presentation of a joint work plan. It noted the intention to revitalize relations and decided to maintain official relations with the Society. Concerning the International Alliance of Women, International Federation of Business and Professional Women, World Association of Girl Guides and Girl Scouts, and World Federation of United Nations Associations, the Board noted that although there had been no joint activities there was an interest
1 2
See Annex 6. Document EB103/23.
-23-
24
EXECUTIVE BOARD, 103rd SESSION
in exploring opportunities to revitalize the relations, and decided to maintain official relations with those organizations for a period of one year to permit preparation of plans for collaboration. In the absence of reports on collaboration from the Collegium lnternationale NeuroPsychopharmacologicum, International Association for Suicide Prevention, International League against Epilepsy, International Union ofNutritional Sciences, and World Federation of the Deaf, the Board decided to defer the review of collaboration until its 105th session. Following up decision EB I 0 I (15), the Board noted that joint work plans had been agreed on with the International Society ofHematology, International Federation of Physical Medicine and Rehabilitation, World Federation of Parasitologists, and World Veterans Federation, which showed every prospect of ensuring productive relations during the coming years and decided, therefore, to maintain official relations with those organizations. On the basis of reports on joint activities presented by the Network of Community-Oriented Educational Institutions for Health Sciences and the World Organization of Family Doctors, the Board decided that the collaboration warranted maintenance of official relations with those organizations. Concerning the International College of Surgeons, the Board noted that although collaboration had declined during the period under review, the review had provided the opportunity to agree on a work plan with WHO. It noted the intention to revitalize relations and decided to maintain official relations with the College. Concerning the International Medical Society of Paraplegia, the Board noted with regret that joint activities had declined, but that an interest in revitalizing relations remained. The Board, therefore, decided to maintain official relations with the Society for a period of one year to permit preparation of a joint work plan. (Eleventh meeting, 1 February 1999)
EB103(3)
Provisional agenda for and duration of the Fifty-second World Health Assembly
The Executive Board approved the provisional agenda ofthe Fifty-second World Health Assembly 1 with inclusion of an item on employment and participation ofwomen in the work of WHO. Recalling its earlier decision 2 that the Fifty-second World Health Assembly should be held at the Palais des Nations in Geneva, Switzerland and open on Monday, 17 May I999, the Board also 'decided that it should close no later than Tuesday, 25 May I999. (Eleventh meeting, I February I999)
1 2
Document EB103/25. Decision EB102(12).
RESOLUTIONS AND DECISIONS
25
EB103(4)
Date and place of the 104th session of the Executive Board
The Executive Board decided that its I04th session should be convened on Wednesday, 26 May I999, at WHO headquarters, Geneva, Switzerland, and should close no later than Thursday, 27 May I999. (Eleventh meeting, I February I999)
EB103(5)
Revised guidelines for the WHO review of dependence-producing psychoactive substances for international control
The Executive Board decided, in view of the continuing need for prompt international regulatory action to respond to changing patterns of drug abuse, that the revised guidelines for the WHO review of dependence-producing psychoactive substances for international control, adopted by the Board at its eightyfifth session, 1 and subsequently modified in their application by the Board at its ninety-third session/ should be further modified in their application as follows: (I) ifthere is (i) a notification from a Party to the Single Convention on Narcotic Drugs, I96I, or to the Convention on Psychotropic Substances, I97I, (ii) an explicit request from the United Nations Commission on Narcotic Drugs concerning international control ofpsychoactive substances, or if (iii) information is brought to WHO's attention that a substance is clandestinely manufactured, of especially serious risk to public health and society, and of no recognized therapeutic utility by any Member State, the Expert Committee on Drug Dependence should critically review such substances as soon as is practicable, and without pre-review being required;
(2) in all other cases, a critical review should be conducted only after the substance in question has been submitted to pre-review and selected for a critical review by the Expert Committee. The Board further decided, in view of the need to update the guidelines adopted by the Board at its eighty-fifth session and, in particular, to clarify the roles of the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of I988, and the Convention on Psychotropic Substances, 197I, to request the Director-General to review and revise the guidelines as necessary, for adoption by the Board at a future session. (Eleventh meeting, I February 1999)
EB103(6)
Award of the Darling Foundation Prize3
The Executive Board, having considered the report of the Darling Foundation Committee, awarded the twentieth Prize to Dr Agostinho Cruz Marques (Brazil) and the twenty-first Prize to Dr Vinod Prakash Sharma (India) for their exceptional achievements in combating malaria in their respective countries. (Eleventh meeting, I February I999)
1
Decision EB85(1 0). Decision EB93( 16). See also document EB I 03/1999/REC/2, eleventh meeting, section I.
2 3
26
EXECUTIVE BOARD, 103rd SESSION
EB103(7)
Award of the Leon Bernard Foundation Prize
The Executive Board, having considered the report of the Leon Bernard Foundation Committee, awarded the Lean Bernard Foundation Prize for 1999 to Mrs Debbie Emma Choongo (Zambia) for her outstanding service in the field of social medicine. (Eleventh meeting, 1 February 1999)
EB103(8)
Award of the Dr A.T. Shousha Foundation Prize
The Executive Board, having considered the report of the Or A.T. Shousha Foundation Committee, awarded the Or A.T. Shousha Foundation Prize for 1999 to Or Benomar Ali (Morocco) for his most significant contribution in the field of clinical neurogenetics in the geographical area in which Or Shousha served the World Health Organization. (Eleventh meeting, 1 February 1999)
EB103(9)
Award of the Ihsan Dogramaci Family Health Foundation Prize and Fellowship
The Executive Board, having considered the report of the Ihsan Dogramaci Family Health Foundation Committee, awarded the Ihsan Dogramaci Family Health Foundation Prize for 1999 to Professor Miinevver Bertan (Turkey) for service accomplished in the field of family health. The Board awarded the Ihsan Dogramaci Family Health Foundation Fellowship to Miss Mangny Justine Coffi (Cote d'Ivoire) to enable her to carry out the research proposed. (Eleventh meeting, 1 February 1999)
EB103(10)
Award of the Sasakawa Health Prize
The Executive Board, having considered the report of the Sasakawa Health Prize Selection Panel, awarded the Sasakawa Health Prize for 1999 to Or Juan Guillermo Ortiz Guier (Costa Rica) and to the Institute of Urban Primary Health Care (South Africa). The Board noted that Or Ortiz Guier would receive an amount of US$ 30 000 and that the Institute of Urban Primary Health Care would receive an amount of US$ 40 000 for their outstanding innovative work in health development. (Eleventh meeting, 1 February 1999)
EB103(11)'
Award of the Francesco Pocchiari Fellowship
The Executive Board, having considered the report of the Francesco Pocchiari Fellowship Committee, awarded the Francesco Pocchiari Fellowship for 1999 to Or Raimonda Lilo Totoni (Albania) in order to enable her to carry out the research proposed. (Eleventh meeting, 1 February 1999)
RESOLUTIONS AND DECISIONS
27
EB103(12)
Award of the United Arab Emirates Health Foundation Prize 1
The Executive Board, having considered the report of the United Arab Emirates Health Foundation Committee, awarded the United Arab Emirates Health Foundation Prize for 1999 to Professor Ismail A. Sallam (Egypt) and to the Centre for Education about Drugs and Treatment of Drugaddicted Persons (KENTHEA) (Cyprus) for their outstanding contribution to health development. The Board noted that the laureates would each receive US$ 20 000. (Eleventh meeting, I February 1999)
EB103(13)
Establishment of the Down Syndrome Research Prize Foundation in the Eastern Mediterranean Region
The Executive Board, having considered a recommendation of the WHO Regional Committee for the Eastern Mediterranean Region, 2 decided to establish the Down Syndrome Research Prize Foundation in the Eastern Mediterranean Region, to be administered by the WHO Regional Office for the Eastern Mediterranean in accordance with the Statutes approved by the Regional Committee at its forty-fifth session in October 1998. (Eleventh meeting, 1 February 1999)
1 2
See also document EB I 03/ 1999/REC/2, eleventh meeting, section I. Resolution EM/RC45/R.9.
ANNEXES
ANNEXl
Revised drug strategy1 Report by the Chairman of the ad hoc working group [EB 103/4 - 25 November 1998]
BACKGROUND 1. In January 1998 the Executive Board at its 101st session considered the Director-General's report on the revised drug strategy. The Board recognized progress made and commended WHO on its work in promoting the essential drugs concept and national drug policies, and in improving drug regulation. In order to address specific constraints on access to drugs, rational use of drugs, and drug quality, it adopted resolution EB10l.R24 on the revised drug strategy. The Fifty-first World Health Assembly was invited to consider the resolution in May 1998. Views differed on a number of points in the resolution and the Health Assembly therefore agreed to establish a drafting group. 2. The drafting group was chaired by Professor J.-F. Girard (France). Despite many hours of discussion in the drafting group, no consensus was reached on language for the resolution and the Health Assembly decided to refer the resolution back to the Executive Board for further consideration at its 103rd session. 2 3. At its I 02nd session, immediately after the Health Assembly, the Executive Board decided on a twotier method of work on the drafting of a resolution for consideration at its 103rd session in January 1999. An ad hoc working group was established, open to all Member States wishing to participate, with a subgroup to assist WHO in its contacts with relevant interested partners. 3 The Board decided that the subgroup would comprise the chairman of the drafting group established during the Fifty-first World Health Assembly, and two Member States from each region, of which at least one would be currently entitled to designate a person to serve on the Executive Board. The regional committees were invited to nominate their representatives to the subgroup. Those nominated were Cape Verde, China, Indonesia, Islamic Republic oflran, Jamaica, Japan, Poland, South Africa, Switzerland, Thailand, United States of America and Yemen. 4. The ad hoc working group and the subgroup met from 12 to 16 October 1998 (list of participants shown in the Appendix). The meetings were chaired by Professor J.-F. Girard (France). The ad hoc working group elected Ms S. Kizildeli (Turkey) and Dr T.J. Stamps (Zimbabwe) as Vice-Chairmen. A total of 59 Member States, including subgroup members, participated in the meeting.
1
See resolution EB103.Rl. Decision WHA51 (I 0). Decision EB 102( 14 ).
2 3
- 31 -
32
EXECUTIVE BOARD, 103rd SESSION
ISSUES 5. In order to assist the ad hoc working group in exploring the complex issues raised by resolution EB 10 1.R24, one full day was devoted to a technical briefing in which relevant interested partners were invited to participate. The technical.briefing covered globalization and pharmaceuticals, including the question of how trade agreements could interfere with or support public health, and strategies for ensuring access to pharmaceuticals. 6. Presentations on globalization and pharmaceuticals were made by representatives of WIPO, WTO, The South Centre, Health Action International, the International Federation of Pharmaceutical Manufacturers' Associations, and the International Pharmaceutical Generic Alliance. A presentation on strategies for ensuring access to pharmaceuticals was made by the WHO Secretariat and reactions were invited from members of the ad hoc working group, including the subgroup, and from those who had made presentations on the globalization and pharmaceuticals issue. 7. The ad hoc working group identified a number of new topics not covered by resolution EB 10 1.R24, which it felt should be the subject of further work by the Secretariat, in particular on access to drugs, transfer of technology and local production, new drugs, counterfeit drugs, human resources, and gender issues. Issues discussed under the topic of access to drugs included supply systems, drug financing, drug insurance, price information and pricing policies, generic drugs, procurement methods, and related matters. However, in order to conclude on the issues in resolution EB101.R24 on which there had been diverging views at the Health Assembly, the ad hoc group decided to concentrate on those topics currently included in the resolution. 8. By the last day of the meeting the ad hoc working group had reached consensus on the text of a resolution to be forwarded to the Executive Board, although, because of lack oftime, certain points raised during the deliberations were not included in the text (e.g. the addition of "transitional countries" in preambular paragraph 10, the addition of preambular paragraphs concerning gender inequalities in health care, and the need to improve access for vulnerable groups). The Secretariat was requested to provide information on the financial implications ofthe resolution.
ACTION BY THE EXECUTIVE BOARD 9. [This paragraph contained a draft resolution which was adopted at the third meeting as resolution EB103.R1.]
ANNEX 1
33
Appendix
LIST OF PARTICIPANTS MEMBERSOFTHESUBGROUP FRANCE
Professeur J.-F. Girard Conseiller d'Etat Conseil d'Etat Paris
(Chairman)
CHINA
Mr Liu Peilong Director-General Department of International Cooperation Ministry of Health Beijing
INDONESIA
Or B. Wasisto Senior Adviser to the Minister of Health Ministry of Health Jakarta
IRAN (ISLAMIC REPUBLIC OF)
Or A. M. Cheragali Secretary Iranian Pharmacopeia Council Tehran
JAMAICA
Mrs G. Alien-Young Ministry of Health Kingston
34 JAPAN
EXECUTIVE BOARD, 103rd SESSION
MrS. Tsuda Deputy Director International Affairs Division Minister's Secretariat Ministry of Health and Welfare Tokyo
POLAND
MsJ. Manko Deputy Minister and Inspector General for Pharmaceuticals Ministry of Health and Social Welfare Warsaw
SOUTH AFRICA
Or I. Roberts Special Adviser Ministry of Health Pretoria
SWITZERLAND
Or S. Zobrist Chef, Affaires internationales Office federal de la Santa publique Berne
THAILAND
Or Pakdee Pothisiri Deputy Permanent Secretary Ministry of Public Health Nonthaburi
UNITED STATES OF AMERICA
Or S. L. Nightingale Associate Commissioner for Health Affairs Food and Drug Administration United States Public Health Service Department of Health and Human Services Washington, D.C.
ANNEX 1 YEMEN
35
Or A. 0. AI-Sallami Under-Secretary for Pharmaceuticals Ministry of Public Health Sana'a
MEMBERS OF THE EXECUTIVE BOARD, ALTERNATES AND ADVISERS
FRANCE
Mrne M. Boccoz Conseiller Mission permanente Geneve
(Alternate to Professor J. Menard)
UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
Mr R. A. Kingharn International Branch Department of Health London
(Alternate to Or K. Calman)
UNITED STATES OF AMERICA
Or J. I. Boufford Dean Robert F. Wagner Graduate School of Public Service New York University New York
36
EXECUTIVE BOARD, 103rd SESSION
MEMBERS OF THE AD HOC WORKING GROUP
ALGERJA M. M. Messaoui Ministre Conseiller Mission permanente Geneve
MrH. Welge Counsellor Permanent Mission Geneva
BANGLADESH ARGENTINA Sr. E. Varela Consejero Misi6n Permanente Ginebra MrK. Rahman Counsellor Permanent Mission Geneva
BELGIUM AUSTRALIA Ms J. Davidson Assistant Secretary Strategic Reform and International Branch Department of Health and Family Services Canberra Mr E. Van der Wal First Secretary Permanent Mission Geneva Ms J. Nielsen Second Secretary Permanent Mission Geneva Ms R. Piggott Counsellor Permanent Mission Geneva M. A. Evrard Division de !'Inspection pharmaceutique Ministere de la Santa publique et de I'Environnement Bruxelles M. S. Legrand Premier Secretaire Mission permanente Geneve M. M. Vinck Premier Secretaire Mission permanente Geneve
BEN IN Mme R. Gnacadja-Bade Conseiller technique aux Affaires pharmaceutiques et laboratoires Cotonou
AUSTRIA Mr C. Dufour Administrator Permanent Mission Geneva Mr U. Frank First Secretary Permanent Mission Geneva
BOLIVIA Mr R. Silveti Director de Relaciones lntemacionales La Paz Sra. S. Avila Seifert Embajadora Representante Permanente Ginebra
ANNEX 1
37
Sr. J. Loayza Barea Ministro Misi6n Pennanente Ginebra
CHINA MrsZhao Lili Deputy Director General State Drug Administration Department of International Cooperation Beijing Mr Hou Zhenyi Counsellor Pennanent Mission Geneva
BRAZIL Mr A. G. Bahadian Deputy Pennanent Representative Geneva Mr C. A. Simas MagalhAes Minister Counsellor Pennanent Mission Geneva Mr L. C. Gasser Second Secretary Pennanent Mission Geneva Mr L. Coelho de Souza Second Secretary Pennanent Mission Geneva Or J. A. Bennudez Professor and Researcher National School of Public Health of the Oswaldo Cruz Foundation Rio de Janeiro
COLOMBIA Srta. A. Oviedo Ministra Consejera Misi6n Pennanente Ginebra
DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA Mr Ri Thae Gun Counsellor Pennanent Mission Geneva
DENMARK CANADA Mr R. Duncan Policy Analyst, Policy Division Bureau of Policy and Coordination, Therapeutic Products Directorate Health Protection Branch, Health Canada Ottawa Ms J. Perlin Counsellor Pennanent Mission Geneva MrQ.-L. Sim First Secretary Pennanent Mission Geneva Mr 0. T. Hansen Counsellor Pennanent Mission Geneva
ECUADOR Sr. F. Meneses Ministro Misi6n Pennanente Ginebra
EGYPT MrT. Adel First Secretary Pennanent Mission Geneva
38
EXECUTIVE BOARD, I 03rd SESSION
EL SALVADOR Sr. M. Castro Grande Ministro Consejero Misi6n Permanente Ginebra,
Mme M. Angone Abena Conseiller Mission permanente Geneve
GERMANY FINLAND DrK. Leppo Director-General Ministl)' of Social Affairs and Health Helsinki Mrs H. Rinkineva Counsellor Permanent Mission Geneva Ms M. Koivusalo Researcher Health and Development Cooperation Group (HEDEC) National Research and Development Centre for Welfare and Health Ministl)' of Social Affairs and Health Helsinki Mr H. Eberle Minister, Deputy Permanent Representative Geneva Dr E. Aderhold First Secreta!)' Permanent Mission Geneva Mr J. WOibers Counsellor Permanent Mission Geneva Ms H. Jirari Third Secreta!)' Permanent Mission Geneva
GHANA FRANCE Mme M. Weii-Guthmann Conseiller Mission permanente Geneve Mme R. Deniau Chargee des Affaires intemationales de I'Afrique du medicament Ministere de I'Emploi et de la Solidarite Paris Mrs M. Jeanfran<;ois Medecin lnspecteur de la Sante Delegation aux Affaires europeennes et intemationales Ministere de I'Emploi et de la Solidarite Paris MrD. Asiama Programme Manager National Drugs Programme Ministl)' of Health
Acera
GREECE Mr D. Coundoureas Counsellor Permanent Mission Geneva
GUATEMALA Sra. C. Rodriguez-Fankhauser Ministro Consejero Misi6n Permanente Ginebra
GABON MmeY. Bike Ambassadeur, Representant permanent Geneve
ANNEX I
39
HONDURAS Sra. G. Bu Figueroa Consejera Encargada de Negocios, a.i. Misi6n P,ermanente Ginebra
Mr P. Hendrasmoro First Secretary Permanent Mission Geneva
IRAN (ISLAMIC REPUBLIC OF) Dr R. Dinarvand Adviser to the Minister of Health and Medical Education for Drug Affairs Ministry of Health and Medical Education Tehran Mr M. Baharvand Third Secretary Permanent Mission Geneva
HUNGARY MrG. Szab6 First Secretary Permanent Mission Geneva
INDIA Mr K. K. Bakshi Secretary Ministry of Health and Family Welfare Department of International Affairs New Delhi Mr R. Shahare First Secretary Permanent Mission Geneva
IRAQ DrN. Mahdy Conseiller, Charge d'affaires, a.i. Mission permanente Geneve M. G. F. Askar Deuxieme Secretaire Mission permanente Geneve
INDONESIA Dr M. Djamaluddin Secretary Directorate-General Drug and Food Control Ministry of Health Department of International Affairs Jakarta Dr A. Soenaryo Chairman Indonesian Pharmaceutical Manufacturers Group Ministry of Health Jakarta DrY. Hudyono Director, Management and Training Consultant Human Resources Development Ministry of Health Jakarta Dr I. Suksmaningsih Director Directorate-General Drug and Food Control Ministry of Health Jakarta
ITALY Professor V. Silano Director, Service for International Relations Ministry of Health Rome Mr G. Schiavoni First Counsellor Permanent Mission Geneva
JAMAICA Miss A. E. Stone Minister Counsellor Permanent Mission Geneva
40
EXECUTIVE BOARD, 103rd SESSION
JAPAN Mr A. Yokomaku Second Secretary Permanent Mission Geneva Mr S. Moriyasu First Secretary Permanent Mission Geneva
NORWAY Mrs H. C. Sundrehagen Director-General Ministry of Health and Social Affairs Oslo Or 0. T. Christiansen Counsellor Permanent Mission Geneva DrM. Andrew Director Norwegian Board of HeaHh Oslo
JORDAN Ms L. Khreis Pharmacist Ministry of Health and Health Care Amman
PAKISTAN Mr M. Akram Ambassador, Permanent Representative Geneva Mrs K. Azhar Counsellor Permanent Mission Geneva
MALAYSIA Mr Raja Nushirwan Zainal Abidin Second Secretary Permanent Mission Geneva
MEXICO Sra. M. L. Sosa Marquez Tercera Secretaria Misi6n Permanente Ginebra
PERU Sr. G. Guillen Primer Secretario Misi6n Permanente Ginebra
MOROCCO MrA. Allouch Premier Secreta ire Mission Permanente Geneve
PHILIPPINES Ms M. E. G. Callangan Second Secretary Permanent Mission Geneva Mr L. J. Palma Attache Permanent Mission Geneva
NETHERLANDS Mr J. Waslander First Secretary Permanent Mission Geneva
ANNEX 1
41
REPUBLIC OF KOREA Mr Young Hwa Yang Counsellor Permanent Mission Geneva.
Mme Thu-Lang Tran Wasescha Chef, Affaires intemationales lnstitut federal de la Propriete intellectuelle Berne Or R. Spang Chef, Division de I'Enregistrement Office intercantonal de ContrOie des Medicaments Berne
RUSSIAN FEDERATION OrA Pavlov Counsellor Permanent Mission Geneva
SYRIAN ARAB REPUBLIC Or K. AI Dayah Deputy Minister of Health Damascus
SLOVAKIA Mr F. Rosocha Second Secretary Permanent Mission Geneva
THAILAND Or Orapan P. Matangkasombut Dean Faculty of Pharmacy Mahidol University Bangkok
SOUTH AFRICA Or D. Johns Counsellor (Health Affairs) Permanent Mission Geneva
TURKEY Ms A. KO«;Ok Deputy Director-General General Directorate of Drugs and Pharmaceutics Ministry of Health Ankara Ms S. Kizildeli First Counsellor Permanent Mission Geneva
SWAZILAND Or S. Shongwe Deputy Director of Health Services Ministry of Health and Social Welfare Mbabane
SWEDEN Mr T. Zetterberg Counsellor Permanent Mission Geneva
UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND Mr G. Warrington First Secretary Permanent Mission Geneva MrA. G. Sims First Secretary Permanent Mission Geneva Mr I. Gillespie Department of Health London
SWITZERLAND Professeur Th. Zeltner Directeur Office federal de la Sante publique Berne
42
EXECUTIVE BOARD, 103rd SESSION
UNITED STATES OF AMERICA Or N. A. Boyer Director for Health and Transportation Programmes Bureau of International and Organization Affairs Department of State Washington, D.C. Mrs L. Vogel Health Attache Permanent Mission Geneva Mr R. G. Loftis Political Counsellor Permanent Mission Geneva MrT. Bums IPR Attache Office of the United States Trade Representative Washington, D.C.
ZIMBABWE Or T. J. Stamps Minister of Health and Child Welfare Ha rare Mr T. J. B. Jokonya Ambassador, Permanent Representative Geneva Mr A. Chidarikire Director, Pharmacy Services Ministry of Health and Child Welfare Ha rare Mr T. T. Chifamba Minister Counsellor Permanent Mission Geneva Mr N. Kanyowa Counsellor Permanent Mission Geneva
URUGUAY Sra. P. Vivas Consejera Misi6n Permanente Ginebra
YEMEN Mr F. AI Obthani Premier Secretaire Mission permanente Geneve
ZAMBIA MrD. Kunda Chief Pharmacist Ministry of Health Lusaka Ms A. Kazhingu Second Secretary Permanent Mission Geneva
ANNEX2
Real Estate Fund 1 Report by the Director-General [EB 103/17 - 13 November 1998]
I.
STATUS OF PROJECTS CURRENTLY UNDERTAKEN BEFORE 31 MAY 1999 Office Project • Six different projects outlined in document EB99/l997/REC/l, Annex 2, pp. 42, 44-45 • Construction of a PAHO/WHO Representative's office in Mexico • Addition of one floor to the regional office building • Renovation/restructuring of regional office building
UNDERTAKEN
OR
TO
BE
Amount US$ 1 654 000 (all projects)
Remarks Cannot be implemented in view of the prevailing situation in the host country Approved by the Health Assembly in 1994 (resolution WHA47.25) but no progress in implementation No government approval, project abandoned Some delay in implementation; completion expected by mid-1999 Contract signed and preliminary construction work started. Expected completion early 2000. Amount allocated from the Real Estate Fund estimated to cover costs for four floors of the projected seven-floor building
Africa
The Americas
250 000
South-East Asia
145 000
400 000
Eastern Mediterranean
• Construction of a new regional office building in Cairo
9 890 000
1
See resolution EBI03.Rl3.
-43-
44
EXECUTIVE BOARD, 103rd SESSION
Headquarters
• Replacement of the local area network (LAN)
6 765 000 (original estimate in Swiss francs and subject to exchange rate fluctuations)
Some delay in implementation, completion and full usage expected by end 1998. Cost overrun expected to be US$ 460 000 or about 7% of previous estimate. Additional expenditure attributed to technological evolution since estimate was made three years ago and to increase in the density of user outlets
11.
ESTIMATED REQUIREMENTS FOR THE PERIOD 1 JUNE 1999 TO 31 MAY
2000 Office Regional Office for the Americas/Pan American Sanitary Bureau
Project Replacement of the waterproofing of the windows and machinehouse roof of the regional office building necessitated by persistent water infiltration
Amount US$ 50 000
Comments The estimated cost of this project is US$ 200 000. It has been past practice for the Real Estate Fund to subsidize 25% of WHO/PAHO real estate projects on the grounds that a quarter of the office staff are financed by WHO
Ill.
FINANCIAL IMPLICATIONS Total requirements US$ 50 000
Unencumbered balance US$ I 060 495 (see Appendix)
Appropriation from casual income US$ None
IV.
ACTION BY THE EXECUTIVE BOARD
[This paragraph contained a draft resolution which was adopted at the tenth meeting as resolution EB103.Rl3.]
REAL ESTATE FUND ESTIMATED SITUATION AS AT 31 DECEMBER 1998 (expressed in US dollars) 1 January 197031 December 1995 1. 2. BALANCE AT 1 JANUARY ................................ INCOME 19988 Total (from inception)
1996-1997
-
11 875 877
I3184075
Balance of Revolving Fund for Real Estate Operations (resolution WHA23.14) .............................. Casual income appropriated (resolutions WHA23.15, WHA24.23, WHA25.38, WHA28.26, WHA29.28, WHA33.15, WHA34.12, WHA35.12, WHA36.17, WHA37.I9, WHA39.5, WHA42.10, WHA43.6, WHA44.29, WHA46.22, WHA47.25, WHA48.22 WHA50.10, WHA50.11) ............................. Transfer from Part II of the Working Capital Fund (resolution WHA23.15) .............................. Rents collected ....................................... Interest ............................................. Other .............................................. Total income Total funds available
68 990
-
-
68 990
"CC "CC
> ~
32 47I 436 1I284I4 8 040 246 6 21I 955 1 567 47 922 608 47 922 608 36 046 73I 11 875 877
10 705 000
82 000 690 000
43 176 436 I128414 8 870 765 7 917 205 1 567 6I 163 377
c. ~
= ...
X N
> z z tTl
748 519 I 015 250
12 468 769 24 344 646 II 160 571 I3 184 075
772 000 I3 956 075 I2 895 580b I 060 495
3. 4.
OBLIGATIONS AND EXPECTED OBLIGATIONS ............ BALANCE AT 31 DECEMBER ............................. a
60 102 882 I 060 495
Estimated.
b Six projects approved for the Regional Office for Africa by resolution WHA50.I 0 for a total of US$ I 654 000 are included, although they are not expected to be realized in the near future because of the present situation in Brazzaville.
I~
ANNEX3
Amendments to Financial Regulations and Rules 1 Report by the Director-General [EB 103118 - 20 October 1998]
1. Pursuant to the suggestion of the Panel of External Auditors of the United Nations, the Specialized Agencies and the International Atomic Energy Agency regarding the formulation of the audit opinion, and the proposal made by the External Auditor in his report to the Health Assembly on the 1996-1997 Financial Report/the Director-General proposes to amend paragraph 5 ofthe additional terms of reference governing the external audit of the World Health Organization, contained in the appendix to the Financial Regulations, as shown in Appendix l ofthis document. 2. The Director-General is proposing amendments to the Financial Rules, as shown in Appendix 2 of this document, to reflect the effect of the new Financial Regulations, adopted in May 1998 by the Health Assembly, in resolution WHA51.20, in respect ofthe application of programme support costs, the financial procedures for the collection of arrears of contributions, the accounting procedure for casual income and the application of the United Nations System Accounting Standards to the preparation and presentation of WHO's accounts and financial reports.
ACTION BY THE EXECUTIVE BOARD 3. [This paragraph contained a draft resolution which was adopted at the tenth meeting as resolution EB103.Rl4.]
1 2
See resolution EB103.Rl4. Document ASI I 11.
-46-
ANNEX3
47
Appendix 1 PROPOSED AMENDMENTS TO FINANCIAL REGULATIONS
PRESENT FINANCIAL REGULATIONS
AMENDED TEXT (with deletions in square brackets and additions underlined)
PURPOSE
Appendix- Additional terms of reference governing the external audit of the World Health Organization
5.
The Auditor(s) shall express and sign an opinion in the following terms:
5.
The Auditor(s) shall express and sign an opinion [in the following terms] on the financial statements ofthe Organization. The opinion shall include the following basic elements: [I/We have examined the following appended financial statements, numbered ... to ... properly identified, and relevant schedules of the World Health Organization for the financial period ended 31 December ... . My/Our examination included a general review of the accounting procedures and such tests of the accounting records and other supporting evidence as 1/we considered necessary in the circumstances. and which states, as appropriate, whether:] (a) [the financial statements present fairly the financial position as at the end of the period and the results of the operations for the period then ended;] identification of the financial statements audited;
I/We have examined the following appended financial statements, numbered ... to ... properly identified, and relevant schedules of the World Health Organization for the financial period ended 31 December ... . My/Our examination included a general review of the accounting procedures and such tests ofthe accounting records and other supporting evidence as Ilwe considered necessary in the circumstances. and which states, as appropriate, whether: (a) the financial statements present fairly the financial position as at the end of the period and the results of the operations for the period then ended;
To bring the format of the audit opinion in line with the text suggested by the Panel ofExternal Auditors ofthe United Nations, the Specialized Agencies and the International Atomic Energy Agency and as proposed by WHO's External Auditor.
48
EXECUTIVE BOARD, 103rd SESSION
(b) the financial statements were prepared in accordance with the stated accounting principles;
(b) [the financial, statements were prepared in accordance with the stated accounting principles;] a reference to the responsibility of the entity's management and the responsibility ofthe Auditor(s): (c) [the accounting principles were applied on a basis consistent with that of the preceding financial period;] a reference to the audit standards followed: (d) [transactions were in accordance with the Financial Regulations and legislative authority.] a description of the work performed:
(c) the accounting principles were applied on a basis consistent with that of the preceding financial period;
(d) transactions were in accordance with the Financial Regulations and legislative authority.
W an expression of opinion on the financial statements as to whether: [(a)] the financial statements present fairly the financial position as at the end of the period and the results of the operations for the period [then ended]; [(b)] the financial statements were prepared in accordance with the stated accounting [principles] policies; [(c)] the accounting [principles] policies were applied on a basis consistent with that of the preceding financial period;
ANNEX3
49
ill [(d)]
an expression of opinion on the compliance of transactions [were in accordance] with the Financial Regulations and legislative authority;
(g) the date of the opinion: (h) the Auditor's(s') name and position:
ill
the place where the report has been signed:
ill should it be necessary. a reference to the report of the External Auditor on the financial statements.
Appendix2
PROPOSED AMENDMENTS TO FINANCIAL RULES
PRESENT FINANCIAL RULES
AMENDED TEXT (with deletions in square brackets and additions underlined) 101.2 The Financial Rules are applicable to all offices and, irrespective of the source of funds, to all financial transactions of the Organization. The latter are also subject to the budgeting and accounting principles and rules applicable to the source of funds concerned. Funds are subject to either annual or biennial cycles, and related expenditures are accounted on [either a cash or] an accrual basis.
PURPOSE
101.2 The Financial Rules are applicable to all offices and, irrespective of the source of funds, to all financial transactions of the Organization. The latter are also subject to the budgeting and accounting principles and rules applicable to the source of funds concerned. Funds are subject to either annual or biennial cycles, and related expenditures are accounted on either a cash or an accrual basis.
To reflect that under all sources of funds expenditures are accounted on an accrual basis.
50
EXECUTIVE BOARD, 103rd SESSION
103.4 The balances ofthe appropriations surrendered in accordance with Rule 103.3 above shall be taken into the accounts as casual income to be used in accordance with Financial Regulation 5.2(d). 103.6 Assessments of Members joining the Organization during the current year but after the close of the Health Assembly shall be dealt with in accordance with Financial Regulations 5.2(c) and 5.8.
103.4 The balances of the appropriations surrendered in accordance with Rule I 03.3 above shall be taken into the accounts as casual income to be used in accordance with Financial Regulation 5.2[(d)]. 103.6 Assessments of Members joining the Organization during the current year but after the close of the Health Assembly shall be dealt with in accordance with Financial Regulations [5.2(c) and 5.8] 5.10. 110.1 Budget and Finance is responsible for establishing and maintaining all official accounts ofthe Organization in a manner consistent with the United Nations System Accounting Standards. 114.1 Budget and Finance shall furnish:
To reflect new reference.
To reflect new reference.
110.1 Budget and Finance is responsible for establishing and maintaining all official accounts of the Organization.
Self-explanatory.
114.1 Budget and Finance shall furnish:
(c) Periodic special statements showing: (i) (ii) Outstanding contributions; Status of advances to the Working Capital Fund; The operation and financial position of the Working Capital Fund including the use of internal borrowing against other available cash resources of the Organization;
(c) Periodic special statements showing: (i) [(ii) Outstanding contributions; Status of advances to the Working Capital Fund;] The operation and financial position of the Working Capital Fund including the use of internal borrowing against other available cash resources of the Organization; To delete the reference to advances to the Working Capital Fund which, following resolution WHA48.21, is no longer relevant.
(iii)
[(iii)] (ill
ANNEX4
Confirmation of amendments to the Staff Rules 1 Report by the Secretariat [EB 103/20 - 9 December 1998]
1. Amendments to the Staff Rules to be made by the Director-General are presented to the Executive Board for confirmation in accordance with StaffRegulation 12.2. 2. These amendments are in line with decisions expected to be taken by the United Nations General Assembly on the basis of recommendations by the International Civil Service Commission in accordance with United Nations common system arrangements. 3. The amendments implement the results of periodic updates by the Commission, based on established methodologies, as summarized in the table below. The text of the amendments is presented in the Appendix. 4. The budgetary implications of the amendments in the 1998-1999 biennium include a small additional cost under the regular budget, which will have to be met from the appropriate allocations established for each ofthe regions and for global and interregional activities.
1
See resolutions EBI03.RI5 and EBI03.RI6.
-51 -
N
Vl
SUMMARY OF AMENDMENTS TO STAFF RULES Subject Base/floor salary (a) Professional and higher categories Adjustment of2.48% in the base/floor salary scale, with effect from 1 March 1999, through consolidation of post adjustment into base salary on a no-loss/no-gain basis. Consequential adjustment in staff assessment rates. As a result of the above, the Director-General proposes in accordance with Staff Regulation 3.1 that the Executive Board recommend to the Fifty-second World Health Assembly the following modifications in the annual net salaries: from US$ 93 671 to US$ 95 995 (D); from US$ 84 821 to US$ 86 926 (S). Similar adjustments to the salary of the Director-General, bearing in mind the terms of paragraph II of her present contract. Increase in annual dependency allowances, with effect from 1 January 1999, as follows: • children: from US$ 1510 to US$ 1730; • disabled children: from US$ 3020 to US$ 3460; • secondary dependant: from US$ 540 to US$ 619 . As a result of a proposed change in the method for computing the reimbursement of additional boarding costs at locations where educational facilities are not available, the Commission is recommending a change in the dollar amount as expressed in the Staff Rule, and establishment of amounts in certain other currencies. ~---------
Action
Amendments to Staff Rules
Comments
StaffRules 330.1.1 and 330.2 (see Appendix)
(b)
Ungraded (Regional Directors and Senior Advisers)
(c)
Director-General
) ) ) ) ) ) ) ) ) ) ) ) )
No cost: all adjustments based on a shift from post adjustment (cost-of-living) to net base salary.
n c::: ....,
tTl
:><
tTl
=2 tTl
~~ 0
> w
0
t:O
Dependency allowances (professional and higher graded categories)
StaffRules 340.1, 340.2 and 340.3 (see Appendix)
a. r/:1 r/:1
tTl
r/:1
~
Education grant
StaffRules 350.1 and 350.2.2 (see Appendix)
-----
~-
--
-
-
-
L__
--
~--
~--
-----
ANNEX4
53
ACTION BY THE EXECUTIVE BOARD 5. The Board at its tenth meeting adopted resolution EB 103 .R 15 confirming the amendments to the Staff Rules contained in the Appendix and resolution EB103.Rl6, recommending a modification in the salaries for ungraded officials and the Director-General.
Appendix TEXT OF AMENDED STAFF RULES
330. 330.1
SALARIES Gross base salaries shall be subject to the following assessments: 330.1.1 For professional and higher graded staff: 1 Assessment per cent Rates with Rates without dependants* dependants* (*as defined in Rules 310.5.1 and 31 0.5.2) First US$ 15 000 ................... . Next US$ 5000 .................... . Next US$ 5000 .................... . Next US$ 5000 .................... . Next US$ 5000 .................... . Next US$ 10 000 ................... . NextUS$10000 ................... . Next US$ 10 000 ................... . Next US$ I 0 000 ................... . Next US$ 15 000 ................... . Next US$ 20 000 ................... . Remaining assessable payments ........ . 9.0 18.1 21.5 24.9 27.9 30.1 31.8 33.5 34.4 35.3 36.1 37.0 11.8 24.4 26.9 31.4 33.4 35.6 38.2 38.8 39.7 40.7 43.9 47.2
Amounts per year
330.2
The following schedule of annual gross and net base salaries shall apply to all professional category and directors' posts with effect from l March 1999:
1
With effect from I March 1999.
VI .j::.
STEPS Level
I
I US$
11 US$
Ill
IV US$
V US$
VI US$
VII US$
VIII US$
IX US$
X US$
XI US$
XII US$
XIII US$
XIV US$
XV US$
US$
P.l
Gross NetD NetS Gross NetD NetS Gross NetD NetS Gross NetD NetS Gross NetD NetS Gross NetD NetS Gross NetD NetS
36 422 37 791 39 157 40 525 41 891 43 258 44 627 46 018 47 418 48 820 30 044 31 001 31 956 32 912 33 867 34 822 35 779 36 734 37 689 38 645 28 341 29 222 30 102 30 983 31 863 32 743 33 625 34 494 35 359 36 226 47 805 49 265 50 721 52 180 53 636 55 098 56 594 58 087 59 585 61 080 62 573 64 071 37953 38949 39942 40937 41930 42925 43920 44913 45909 46903 47896 48892 35 598 36 501 37 401 38302 39202 40105 41021 41934 42851 43766 44680 45596 59386 61057 62731 64400 66088 67782 69477 71174 72867 74564 76275 77994 79711 81 430 83 148 45 777 46 888 48 001 49 111 50224 51335 52447 53560 54671 55 784 56 895 58 007 59 118 60 230 61 342 42 730 43 752 44 776 45 798 46 821 47 843 48 865 49 888 50 909 51 932 52 951 53 970 54 989 56 008 57 027 72 631 74 438 76 257 78 085 79 917 81 743 83 573 85 403 87 232 89 060 90 898 92 756 94 606 96 459 98 311 54 516 55 701 56883 58066 59251 60433 61617 62801 63984 65167 66349 67536 68718 69902 71986 50 767 51 856 52 940 54 024 55 111 56 194 57 279 58 364 59 448 60 533 61 594 62 636 63 674 64 713 65 753 88 099 89 975 91 875 93 775 95 674 97 571 99 471 101 371 103 269 105 169 107 067 108 966 110 878 64545 65759 66973 68187 69401 70613 71827 73041 74254 75468 76681 77 894 79 108 59 963 61 075 62 142 63 208 64 273 65 337 66 403 67 469 68 534 69 600 70 665 71 730 72 773 99 848 101 948 104 047 106 142 108 243 110 346 112 476 114 605 116 732 72068 73410 74751 76090 77432 78773 80115 81456 82796 66615 67793 68970 70146 71324 72493 73617 74741 75864 112824115311117797120283122768125256 80 334 81 901 83 467 85 033 86 599 88 166 73 801 75 114 76 427 77 739 79 052 80 365
P.2
P.3
I~ c < m >-l l:;1j
0
P.4
~0
> :::0 ...... 0 w '"I
0..
P.5
m m m 0
m
z
P.6/ D.1
D.2
D = Rate applicable to staff members with a dependent spouse or dependent child. S = Rate applicable to staff members with no dependent spouse or dependent child.
ANNEX4
55
340.
DEPENDANTS' ALLOWANCES A staff member in a post of professional or higher grade, except for short-term staff members appointed under Rule 1320 or consultants appointed under Rule 1330, is entitled to a dependant's allowance for dependants as defined in Rule 31 0.5, to be paid as follows:
340.1
US$ 1730 per annum for a child, except that in cases where there is no dependent spouse the first dependent child is not entitled to an allowance. The entitlement shall be reduced by the amount of any benefit paid from any other public source by way of social security payments, or under public law, by reason of such child. US$ 3460 per annum for a child who is physically or mentally incapacitated subject to the conditions defined in Rule 340.1 except that if the staff member has no dependent spouse and receives the "with dependant" rate of net salary by virtue of such a child, an allowance of US$ 1730 shall be payable. US$ 619 per year for a father, mother, brother or sister.
340.2
340.3
350. 350.1
EDUCATION GRANT An internationally recruited staff member shall be entitled to an education grant, except as indicated in Rule 350.3. The amount of the grant payable under this Rule shall be 75% of the education expenses actually incurred and admissible under Rule 350.2. The maximum grant per child per year shall not exceed a total payment of US$ 9750 or, for expenses incurred in certain currencies as determined by the Director-General on the basis of procedures agreed among the international organizations concerned, an amount established in those currencies. For staff members at certain designated official stations, the amount of the grant in respect of primary and secondary education shall be increased by an additional amount corresponding to 100% of boarding costs up to US$ 4746 per child per year or, for expenses incurred in certain local currencies as determined by the Director-General on the basis of procedures agreed among the international organizations concerned, an amount established in those currencies.
350.2.2
the cost of full-time attendance at an educational institution outside the country or area of the official station, including the cost of board if provided by the institution. Where board is not provided by the institution, a flat amount is paid in lieu. The flat amount per child per year shall be US$ 3164 or, for expenses incurred in certain currencies as determined by the Director-General on the basis of procedures agreed among the international organizations concerned, an amount established in those currencies. For staff members at certain designated official stations the flat amount in respect of primary and secondary education is US$ 4746, or for expenses incurred in certain currencies as determined by the Director-General on the basis of procedures agreed among the international organizations concerned, an amount established in those currencies.
ANNEX5
Reform of the Health Assembly 1 Report by the Secretariat [EB103/35- 25 January 1999]
BACKGROUND I. In response to the request to add a supplementary agenda item to the agenda of the I 03rd session of the Executive Board, 2 the Secretariat, in consultation with the Chairman of the Board, has prepared this report in order to assist the Board in its deliberations on one aspect of the work of the Health Assembly, namely, the interworking of high-level policy-makers participating in governing bodies. 2. Article 18(d) of the Constitution of WHO stipulates that one of the functions of the Health Assembly shall be to review and approve reports and activities of the Director-General. Rule 5 of the Rules of Procedure ofthe Health Assembly further specifies that the agenda of the Health Assembly shall include the annual report ofthe Director-General on the work of the Organization. 3. The Health Assembly has so far considered the annual report of the Director-General in plenary meetings and, in general, the chief delegate has addressed the plenary. The arrangements for the general discussion in plenary meetings on the annual report of the Director-General were defined by the Health Assembly in 1967. 3 In 1997, the Health Assembly approved new arrangements for the conduct of this discussion in plenary meetings, as follows: • delegates are requested to limit to five minutes their statements in such discussions; • delegates wishing to do so may submit prepared statements of not more than 600 words for inclusion in the verbatim records of the plenary meetings; • the statements should focus on the theme of The world health report. 4
1
See resolution EBI03.RI9. See document EB I 0311 Add. I. Resolution WHA20.2. Resolution WHA50.18.
2 3 4
-56-
ANNEX5
57
ISSUES 4. In recent years, organizations of the United Nations system have established mechanisms to facilitate the interworking of high-level policy-makers participating in their governing bodies. Examples are the high-level segment of the Economic and Social Council and the WTO ministerial meeting. The Executive Board has also expressed concern that the present format for discussion of the annual report of the DirectorGeneral does not lend itselfto a meaningful policy debate. 1 5. The Health Assembly provides an ideal forum in which to debate and exchange ideas on themes of the day. In order to make better use of this forum and to establish a format that is lively, interesting, and useful to Member States, the Secretariat and the general public, arrangements for the conduct of the general discussion could be redefined, as follows: • chief delegates would be invited to participate in, say, one of two high-level meetings of the Health Assembly, which would be held over two meetings of the plenary; • each high-level meeting would focus on one or two themes contained in the annual report of the Director-General, which would be announced when the provisional agenda for the Health Assembly is prepared by the Executive Board; • at each high-level meeting a renowned international figure would deliver the key-note address on the selected theme; • debate and interchange of ideas would be encouraged during the meetings. 6. Any new arrangements would need to be considered by the Fifty-second World Health Assembly in May 1999. It would be possible, however, as an interim measure, to incorporate in the timetable of the Fifty-second World Health Assembly a one-half day session organized along the lines described above, in addition to a discussion of the annual report of the Director-General in plenary, in accordance with current procedures.
1
See document EB97/1996/REC/2, pp. 220-221.
ANNEX6
N ongovernmental organizations maintained in official relations with WHO by virtue of decision EB103(2) [EB 103/23 - 28 January 1999]
Alzheimer's Disease International Commonwealth Association for Mental Handicap and Developmental Disabilities Inclusion International Industry Council for Development Inter-African Committee on Traditional Practices affecting the Health of Women and Children International Alliance of Women International Association for Adolescent Health International Association for Maternal and Neonatal Health International Association for the Scientific Study oflntellectual Disabilities International Association of Agricultural Medicine and Rural Health International Bureau for Epilepsy International College of Surgeons International Commission on Occupational Health International Confederation of Midwives International Council for Control oflodine Deficiency Disorders International Council of Women International Council on Alcohol and Addictions International Council on Social Welfare International Ergonomics Association International Federation of Business and Professional Women International Federation of Chemical, Energy, Mine and General Workers' Unions International Federation of Fertility Societies International Federation of Gynecology and Obstetrics International Federation of Multiple Sclerosis Societies International Federation ofPhysical Medicine and Rehabilitation International Federation on Ageing International Lactation Consultant Association International Medical Society of Paraplegia International Occupational Hygiene Association International Pediatric Association International Planned Parenthood Federation International Society for Biomedical Research on Alcoholism International Society for Prosthetics and Orthotics International Society for the Study of Behavioural Development International Society of Hemato logy
-58-
ANNEX6
59
International Special Dietary Foods Industries International Union for Health Promotion and Education International Women's Health Coalition La Leche League International Medical Women's International Association Network of Community-Oriented Educational Institutions for Health Sciences Rehabilitation International Soroptimist International The Population Council World Assembly of Youth World Association of Girl Guides and Girl Scouts World Association for Psychosocial Rehabilitation World Confederation for Physical Therapy World Federation for Mental Health World Federation of Chiropractic World Federation ofNeurology World Federation ofNeurosurgical Societies World Federation of Occupational Therapists World Federation ofParasitologists World Federation of United Nations Associations World Organization of Family Doctors World Organization of the Scout Movement World Psychiatric Association World Veterans Federation
INDEX TO RESOLUTIONS AND DECISIONS
(Numerals bearing the symbol "EBJ03.R... "refer to resolutions; numerals alone in parentheses refer to decisions)
Page Americas, appointment of Regional Director (EB 103 .R2) ......... . Assessed contributions, status of collection (EB103.R12) ....... . Audit Committee, establishment of (EB103.R8) ................ . Financial Regulations and Rules, amendments to (EB103.R14) ... . Francesco Pocchiari Fellowship (I I) .. .
Page
4 I6 8
I8 26
Bernard, Leon, Foundation Prize (7) ... Budget presentation and process (EBI03.R6) ................ .
26
5
German Pharma Health Fund e. V. (EBI03.RI8) ............... . Guidelines, revised, for WHO review of dependence-producing psychoactive substances for international control (5) ....... .
20
25
Darling Foundation Prize (6) ........ Director General, salary of (EB103.RI6) ............... Dogramaci, Ihsan, Family Health Foundation Prize (9) ......... Down Syndrome Research Prize Foundation establishment of(l3) .................... Drug strate~y, revised (EBI03.R1) ...
. . .
25 I8 26 Han, Dr S.T., expression of appreciation (EB I 03 .R5) ...... . Health Assembly, reform of (EBI03.RI9) ............... .
5 2I
. .
27 I Ihsan Dogramaci Family Health Foundation Prize (9) ......... . International Federation of AntiLeprosy Associations (EBI03.RI8) ............... . International Society of Andrology (EBI03.RI8) ............... . 26
Eastern Mediterranean Region, Down Syndrome Research Prize Foundation establishment of(13) .................... . Executive Board, Audit Committee, establishment of (EB 103 .R8) .............. . date and place of I 04th session ( 4) .. representatives at Fifty-second World Health Assembly (1) ..
20 20
27
8 25 23
Leon Bernard Foundation Prize (7) ....
26
Malaria, Roll Back (EBI03.R9) ...... .
9
- 6I -
62
EXECUTIVE BOARD, 103rd SESSION
Page N ongovemmental organizations Standing Committee report (EB103.R18) ............. . review (2) .................... . Salaries for ungraded posts and Director-General (EB103.R16) ............... . Sasakawa Health Prize ( 10) ......... . Shousha, Dr A.T. Foundation Prize (8) ................... . South-East Asia, appointment of Regional Director (EB 103 .R3) ... Staff Rules, amendments to (EB103.R15) ............... .
Page
20 23
18 26 26 4
Pocchiari, Francesco, Fellowship (11) .. Poliomyelitis, eradication of (EB103.R10) ............... . Proposed budget 2000-2001, presentation and process (EB 103 .R6) ................ . Psychoactive substances, dependenceproducing, revised guidelines for international control (5) .....
26 11
18
5
25
Tobacco control, WHO framework convention (EB 103.R11) ...... . Travel expenses for attendance at regional committees (EB103.R7) ................ .
12
7
Real Estate Fund (EB103.R13) ...... Regional Committees, travel expenses for attendance at (EB103.R7) ................ Regional Director for the Americas, appointment (EB103.R2) ...... Regional Director for South-East Asia, appointment (EB103.R3) ................ Regional Director for the Western Pacific, appointment (EB103.R4) ................ expression of appreciation (EB103.R5) .............. Roll Back Malaria (EB103.R9) ......
.
17
. .
7 4
Ungraded posts and Director-General, salaries of staff (EB 103. R 16) .... UNICEF /UNFP A Coordinating Committee on Health: terms of reference (EB 103 .R 17) ..... . United Arab Emirates Health Foundation Prize (12) ......... .
18
19 27
.
4
. . .
4
5 9
Western Pacific, appointment of Regional Director (EB 103 .R4) ... World Health Assembly, Fifty-second appointment of representatives of Executive Board (1) ....... . provisional agenda and duration (3) reform of(EB103.R19) .......... .
4
23 24 21